Isolated conjugated hyperbilirubinemia with rifampicin and cross-reaction with rifabutin: A drug-endogenous substance interaction case report

Therapie. 2023 Oct 10:S0040-5957(23)00143-9. doi: 10.1016/j.therap.2023.09.006. Online ahead of print.
No abstract available

Keywords: Adverse drug reaction; Isolated hyperbilirubinemia; Rifabutin; Rifampicin; Rifamycin antibiotics.

Publication types

  • Letter